Global leaders since 2012

Our expertise in genomics-based cancer assays, bioinformatics, and machine learning runs deep thanks to the strong foundation laid by our scientific and medical leaders, Drs. Samuel Aparicio, David Huntsman, and Sohrab Shah.

Our founders have earned international recognition for their work in cancer research. Collectively, they’ve published more than 400 peer-reviewed articles in the fields of cancer genomics, diagnosis, and bioinformatics, including in the New England Journal of Medicine, Science, Nature and Nature Genetics.

Investor Relations

At Canexia Health, we make high-quality cancer genomic information accessible and affordable with our clinically-validated assays, informatics, and support. Visit our Investor Relations page for information for stockholders, potential investors, and financial analyst.

Learn More

Leadership Team

Join our team

Ready to join our high-performing team? We can’t wait to hear from you.

View Openings